NCT07135063

Brief Summary

The goal of this study is to find out whether cranial nerves are affected in people with Behçet's Disease (BD), and how this might relate to other disease features. Cranial nerves control important functions such as vision, facial movement, hearing, swallowing, and balance. The main questions this study will address are:

  • Do people with BD have changes in cranial nerve function compared to healthy individuals?
  • Are these changes linked to disease duration, symptoms, or lab results? Participants will:
  • Answer questions about their medical history and BD symptoms
  • Complete questionnaires on daily function, mood, and autonomic symptoms
  • Have a clinical examination of all 12 cranial nerves
  • Undergo non-invasive electrical tests to assess nerve function This study will not involve any medications. All procedures will be completed in one visit.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
4mo left

Started Oct 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Oct 2025Sep 2026

First Submitted

Initial submission to the registry

July 22, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 21, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

August 21, 2025

Status Verified

August 1, 2025

Enrollment Period

3 months

First QC Date

July 22, 2025

Last Update Submit

August 13, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Establish the presence or absence of cranial nerve involvement in BD.

    Upon patient inclusion EMG and clinical examination is carried out

    Once: Upon patient inclusion

Secondary Outcomes (1)

  • Investigate relation between disease duration (months) and cranial nerve involvement in BD patients

    Once: Upon patient inclusion

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Target Population: Patient Group: Diagnosed Behçet's patients aged 18-75 years Control Group: Age- and gender-matched healthy individuals without neurological, autoimmune, or inflammatory diseases Sample Size: Minimum 30 Behçet patients Minimum 30 healthy controls Recruitment: Participants will be recruited from Marmara University Pendik Research and Education Hospital. Healthy controls will be volunteers among hospital staff and relatives of patients.

You may qualify if:

  • Aged 18-75
  • Diagnosed with BD according to ACR/EULAR 2013 criteria (patient group)
  • Healthy with no relevant medical history (control group)

You may not qualify if:

  • Conditions affecting CN assessment (e.g., facial trauma, surgery, radiotherapy)
  • Other rheumatologic or autoimmune diseases
  • Psychiatric disorders, alcohol/substance abuse
  • Pregnant women
  • Use of pacemakers or recent botox to masseter muscle

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara Üniversitesi Tıp Fakültesi

Istanbul, Maltepe, 34854, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Behcet SyndromeCranial Nerve Diseases

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesUveitis, AnteriorPanuveitisUveitisUveal DiseasesEye DiseasesVasculitisVascular DiseasesCardiovascular DiseasesHereditary Autoinflammatory DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin Diseases, GeneticSkin DiseasesSkin and Connective Tissue DiseasesSkin Diseases, VascularNervous System Diseases

Central Study Contacts

Reihaneh Houshyar Zarnaghi, Assistant Doctor

CONTACT

Mehmet Tuncay Duruöz, Professor Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 22, 2025

First Posted

August 21, 2025

Study Start

October 1, 2025

Primary Completion

January 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

August 21, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations